Inside Innovation

Curi Bio, a Seattle-based biotech company, has significantly expanded its operations with a new 13,942-square-foot lease in the Interbay neighborhood of Seattle.  Eric Swanson, vice

Absci, a generative AI drug creation company headquartered in Vancouver, Washington, announced its partnership with Memorial Sloan Kettering Cancer Center to co-develop up to six

A research team led by the University of Washington will receive up to $21.2 million as part of Biden’s Cancer Moonshot initiative to reduce cancer

Xaira Therapeutics – a spinout from the University of Washington’s Institute for Protein Design (IPD) – merges AI with science to create generative models for

Headquartered in Seattle, Sana Biotechnology opened its new 80,000 square-foot manufacturing facility in Bothell, Washington, which will house Sana’s proprietary cancer drug program. Sana utilizes

AGC Biologics, a Seattle-based biomanufacturer, announced that its Seattle campus achieved a new milestone for regulatory compliance in partnership with the Food and Drug Administration

Outpace Bio, a Seattle-based startup using AI to design proteins for cancer therapies targeting solid tumors, has secured $144 million in new funding from investors.

The University of Washington has been awarded a $50 million grant from the National Science Foundation to spearhead the Safeguarding the Entire Community of the

Kestra Medical Technologies, a Kirkland-based biotechnology company specializing in wearable defibrillators, has raised $196 million in its latest funding round. In a recent release, CEO

Seattle and the Greater Puget Sound continue to rank among the top biopharma clusters in the U.S., securing the #10 spot this year.  GEN’s four

The Allen Institute for AI (AI2) has leased a full floor in the Northlake Commons building, encompassing 50,000 square feet.  Founded by the late Microsoft